{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:18:57Z","timestamp":1787242737438,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1208\/s12249-019-1581-y","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T15:02:26Z","timestamp":1577113346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development of Methotrexate and Minocycline-Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis"],"prefix":"10.1208","volume":"21","author":[{"given":"Kumar","family":"Janakiraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateshwaran","family":"Krishnaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaidevi","family":"Sethuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruckmani","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"issue":"4","key":"1581_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tips.2015.02.001","volume":"36","author":"MI Koenders","year":"2015","unstructured":"Koenders MI, van den Berg WB. Novel therapeutic targets in rheumatoid arthritis. Trends Pharmacol Sci. 2015;36(4):189\u201395.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1581_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hcl.2010.09.002","volume":"27","author":"JM Kahlenberg","year":"2011","unstructured":"Kahlenberg JM, Fox DA. Advances in the medical treatment of rheumatoid arthritis. Hand Clin. 2011;27(1):11\u201320.","journal-title":"Hand Clin"},{"issue":"9339","key":"1581_CR3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(02)11159-7","volume":"360","author":"J Sibilia","year":"2002","unstructured":"Sibilia J, Marietta X. Methotrexate treatment and mortality in rheumatoid arthritis. Lancet J. 2002;360(9339):1096\u20137.","journal-title":"Lancet J"},{"key":"1581_CR4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkh191","volume":"53","author":"ESR Darley","year":"2004","unstructured":"Darley ESR, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother. 2004;53:928\u201335.","journal-title":"J Antimicrob Chemother"},{"issue":"61","key":"1581_CR5","first-page":"S21","volume":"5","author":"B Cronstein","year":"2010","unstructured":"Cronstein B. How does methotrexate suppress inflammation? Clin Exp Rheumatol. 2010;5(61):S21\u20133.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1581_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.26417\/ejis.v2i1.p9-16","volume":"1","author":"A Tomescu","year":"2016","unstructured":"Tomescu A, Sirbu R, Paris S, Cadar E, Erimia CL, Tomescu CL. Methotrexate. Therapy in obstetrica\u013a diseases. Eur J Interdiscip Stud. 2016;1(4):9\u201316.","journal-title":"Eur J Interdiscip Stud"},{"issue":"4","key":"1581_CR7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","volume":"4","author":"ESL Chan","year":"2002","unstructured":"Chan ESL, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res. 2002;4(4):266\u201373.","journal-title":"Arthritis Res"},{"issue":"3","key":"1581_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JA Wessels","year":"2008","unstructured":"Wessels JA, Huizinga TW, Guchelaar HJ. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology. 2008;47(3):249\u201355.","journal-title":"Rheumatology"},{"issue":"1","key":"1581_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0162-3109(99)00185-X","volume":"47","author":"JY Sung","year":"2000","unstructured":"Sung JY, Hong JH, Kang HS, Choi I, Lim SD, Lee JK, et al. Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology. 2000;47(1):35\u201344.","journal-title":"Immunopharmacology"},{"issue":"3","key":"1581_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2133.2008.08876.x","volume":"160","author":"S Prey","year":"2009","unstructured":"Prey S, Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br J Dermatol. 2009;160(3):622\u20138.","journal-title":"Br J Dermatol"},{"key":"1581_CR11","first-page":"6603","volume":"10","author":"AL Boechat","year":"2015","unstructured":"Boechat AL, de Oliveira CP, Tarrago AM, da Costa AG, Malheiro A, Guterres SS, et al. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model. Int J Nanomedicine. 2015;10:6603\u201314.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"1581_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","volume":"169","author":"N Garrido-Mesa","year":"2013","unstructured":"Garrido-Mesa N, Zarzuelo A, Galvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169(2):337\u201352.","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1581_CR13","first-page":"1502","volume":"19","author":"P Langevitz","year":"1992","unstructured":"Langevitz P, Bank I, Zemer D, Book M, Pras M. Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol. 1992;19(10):1502\u201314.","journal-title":"J Rheumatol"},{"issue":"10","key":"1581_CR14","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A","volume":"44","author":"JR O\u2019Dell","year":"2001","unstructured":"O\u2019Dell JR, Blakely KW, Mallek JA, Eckhoff PJ, Leff RD, Wees SJ, et al. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum. 2001;44(10):2235\u201341.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1581_CR15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","volume":"122","author":"BC Tilley","year":"1995","unstructured":"Tilley BC, Alarcon GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, et al. Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann Intern Med. 1995;122(2):81\u201390.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1581_CR16","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/STROKEAHA.110.582601","volume":"4","author":"SC Fagan","year":"2010","unstructured":"Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke. 2010;4(10):2283\u201397.","journal-title":"Stroke."},{"key":"1581_CR17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1039\/C7BM00254H","volume":"5","author":"Q Wang","year":"2017","unstructured":"Wang Q, Su X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci. 2017;5:1407\u201320.","journal-title":"Biomater Sci"},{"issue":"1","key":"1581_CR18","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.3390\/nano8010042","volume":"8","author":"SY Chuang","year":"2018","unstructured":"Chuang SY, Lin CH, Huang TH, Fang JY. Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials. 2018;8(1):E42.","journal-title":"Nanomaterials"},{"issue":"13","key":"1581_CR19","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2217\/nnm.15.45","volume":"10","author":"LK Prasad","year":"2015","unstructured":"Prasad LK, O\u2019Mary H, Cui Z. Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine. 2015;10(13):2063\u201374.","journal-title":"Nanomedicine"},{"issue":"2\u20133","key":"1581_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-3659(99)00073-5","volume":"60","author":"MF Zambaux","year":"1999","unstructured":"Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release. 1999;60(2\u20133):179\u201388.","journal-title":"J Control Release"},{"issue":"8","key":"1581_CR21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard.2004.030759","volume":"64","author":"M Higaki","year":"2005","unstructured":"Higaki M, Ishihara T, Izumo N, Takatsu M, Mizushima Y. Treatment of experimental arthritis with poly(d,l-lactic\/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis. 2005;64(8):1132\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1581_CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40744-017-0086-y","volume":"4","author":"H Tahir","year":"2017","unstructured":"Tahir H, Deodhar A, Genovese M, Takeuchi T, Aelion J, Van den Bosch F, et al. Secukinumab in active rheumatoid arthritis after anti-TNF\u03b1 therapy: a randomized, double-blind placebo-controlled phase 3 study. Rheumatol Ther. 2017;4(2):475\u201388.","journal-title":"Rheumatol Ther"},{"key":"1581_CR23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12906-016-1470-9","volume":"16","author":"V Kumar","year":"2016","unstructured":"Kumar V, Bhatt PC, Rahman M, Patel DK, Sethi N. Kumar Melastoma malabathricum Linn attenuates complete freund\u2019s adjuvant induced chronic inflammation in Wistar rats via inflammation response. BMC Complement Altern Med. 2016;16:510.","journal-title":"BMC Complement Altern Med"},{"issue":"1\u20132","key":"1581_CR24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2007.04.031","volume":"342","author":"Y Dong","year":"2007","unstructured":"Dong Y, Feng SS. Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Int J Pharm. 2007;342(1\u20132):208\u201314.","journal-title":"Int J Pharm"},{"issue":"2","key":"1581_CR25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejps.2013.02.006","volume":"49","author":"Y Guo","year":"2013","unstructured":"Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175\u201386.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1581_CR26","first-page":"561","volume":"5","author":"VJ Mohanraj","year":"2006","unstructured":"Mohanraj VJ, Chen Y. Nanoparticles\u2014a review. Trop J Pharm Res. 2006;5(1):561\u201373.","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"1581_CR27","first-page":"17","volume":"10","author":"J Emami","year":"2015","unstructured":"Emami J, Mohiti H, Hamishehkar H, Varshosaz J. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and box-Behnken design. Res Pharm Sci. 2015;10(1):17\u201333.","journal-title":"Res Pharm Sci"},{"key":"1581_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12951-019-0490-2","volume":"17","author":"S Malik","year":"2019","unstructured":"Malik S, Bahal R. Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro. J Nanobiotechnol. 2019;17:57.","journal-title":"J Nanobiotechnol"},{"key":"1581_CR29","doi-asserted-by":"crossref","first-page":"109766","DOI":"10.1016\/j.msec.2019.109766","volume":"103","author":"RM Trujillo-Nolasco","year":"2019","unstructured":"Trujillo-Nolasco RM, Morales-Avila E, Ocampo-Garcia BE, Ferro-Flores G, Gibbens-Bandala BV, Escudero-Castellanos A, et al. Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis. Mater Sci Eng C. 2019;103:109766.","journal-title":"Mater Sci Eng C"},{"issue":"10","key":"1581_CR30","first-page":"19670","volume":"8","author":"SB Sun","year":"2015","unstructured":"Sun SB, Liu P, Shao FM, Miao QL. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int J ClinExp Med. 2015;8(10):19670\u201381.","journal-title":"Int J ClinExp Med"},{"issue":"4","key":"1581_CR31","first-page":"208","volume":"3","author":"NM Mahajan","year":"2011","unstructured":"Mahajan NM, Sakarkar DM, Manmode AS. Preparation and characterization of meselamine loaded PLGA nanoparticles. Int J Pharm Pharm Sci. 2011;3(4):208\u201314.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1581_CR32","first-page":"221","volume":"7","author":"TS Kashi","year":"2012","unstructured":"Kashi TS, Eskandarion S, Esfandyari-Manesh M, Amin SM, Samadi N, Fatemi SM, et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid\/oil\/water ion pairing method. Int J Nanomedicine. 2012;7:221\u201334.","journal-title":"Int J Nanomedicine"},{"key":"1581_CR33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1015841715384","volume":"8","author":"S Cohen","year":"1991","unstructured":"Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic\/glycolic acid) microspheres. Pharm Res. 1991;8:713\u201320.","journal-title":"Pharm Res"},{"key":"1581_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","volume":"75","author":"A Kumari","year":"2010","unstructured":"Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B. 2010;75:1\u201318.","journal-title":"Colloids Surf B"},{"key":"1581_CR35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ijbiomac.2016.11.111","volume":"95","author":"A Singh","year":"2017","unstructured":"Singh A, Thotakura N, Kumar R, Singh B, Sharma G, Katare OP, et al. PLGA-Soya lecithin based micelles for enhanced delivery of methotrexate: cellular uptake, cytotoxic and pharmacokinetic evidences. Int J Biol Macromol. 2017;95:750\u20136.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1581_CR36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","volume":"133","author":"F Danhier","year":"2009","unstructured":"Danhier F, Lecouturier N, Vroman B, Jerome C, Marchand-Brynaert J, Feron O, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release. 2009;133(1):11\u20137.","journal-title":"J Control Release"},{"key":"1581_CR37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.colsurfb.2012.06.024","volume":"101","author":"NM Khalil","year":"2013","unstructured":"Khalil NM, do Nascimento TC, Casa DM, Dalmolin LF, de Mattos AC, Hoss I, et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA\u2013PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces. 2013;101:353\u201360.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1581_CR38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2017.03.012","volume":"252","author":"MM Alam","year":"2017","unstructured":"Alam MM, Han HS, Sung S, Kang JH, Sa KH, Al Faruque H, et al. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis. J Control Release. 2017;252:62\u201372.","journal-title":"J Control Release"},{"key":"1581_CR39","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.2147\/IJN.S140992","volume":"12","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhao M, Yu C, Zhang X, Liu J, Cheng X, et al. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomedicine. 2017;12:6735\u201346.","journal-title":"Int J Nanomedicine"},{"key":"1581_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.msec.2017.08.055","volume":"81","author":"M Dhanka","year":"2017","unstructured":"Dhanka M, Shetty C, Srivastava R. Injectable methotrexate loaded polycaprolactone microspheres: physicochemical characterization, biocompatibility, and hemocompatibility evaluation. Mater Sci Eng C. 2017;81:542\u201350.","journal-title":"Mater Sci Eng C"},{"key":"1581_CR41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.colsurfb.2018.06.016","volume":"170","author":"S Zhang","year":"2018","unstructured":"Zhang S, Wu L, Cao J, Wang K, Ge Y, Ma W, et al. Effect of magnetic nanoparticles size on rheumatoid arthritis targeting and photothermal therapy. Colloids Surf B: Biointerfaces. 2018;170:224\u201332.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"1","key":"1581_CR42","first-page":"64","volume":"3","author":"S Karthikeyan","year":"2013","unstructured":"Karthikeyan S, Prasad NR, Ganamani A, Balamurugan E. Anticancer activity of resveratrol loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomed PrevNutr. 2013;3(1):64\u201373.","journal-title":"Biomed PrevNutr"},{"issue":"1","key":"1581_CR43","first-page":"87","volume":"5","author":"N Kumar","year":"2018","unstructured":"Kumar N, Salar RK, Prasad M, Ranjan K. Synthesis, characterization and anticancer activity of vincristine loaded folic acid-chitosan conjugated nanoparticles on NCI-H460 non-small cell lung cancer cell line. EJBAS. 2018;5(1):87\u201399.","journal-title":"EJBAS"},{"issue":"10","key":"1581_CR44","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/ijms19102894","volume":"19","author":"Z Pang","year":"2018","unstructured":"Pang Z, Wang G, Ran N, Lin H, Wang Z, Guan X, et al. Inhibitory effect of methotrexate on rheumatoid arthritis inflammation and comprehensive metabolomics analysis using ultra-performance liquid chromatography-quadrupole time of flight-mass spectrometry (UPLC-Q\/TOF-MS). Int J Mol Sci. 2018;19(10):2894.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1581_CR45","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1021\/acsbiomaterials.8b00738","volume":"4","author":"N Feng","year":"2018","unstructured":"Feng N, Yang M, Feng X, Wang Y, Chang F, Ding J. Reduction-responsive polypeptide nanogel for intracellular drug delivery in relieving collagen-induced arthritis. ACS Biomater Sci Eng. 2018;4(12):4154\u201362.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"1581_CR46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13287-017-0623-1","volume":"8","author":"AD Guerra","year":"2017","unstructured":"Guerra AD, Rose WE, Hematti P, Kao WJ. Minocycline modulates NF\u03baB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus inmesenchymal stromal\/stem cells. Stem Cell Res Ther. 2017;8(1):171.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"1581_CR47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1756-185X.12805","volume":"19","author":"I Tekeoglu","year":"2016","unstructured":"Tekeoglu I, Gurol G, Harman H, Karakece E, Ciftci IH. Overlooked hematological markers of disease activity in rheumatoid arthritis. Int J Rheum Dis. 2016;19(11):1078\u201382.","journal-title":"Int J Rheum Dis"},{"key":"1581_CR48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","volume":"17","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47\u201358.","journal-title":"Curr Pharm Des"},{"key":"1581_CR49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/molecules24010146","volume":"24","author":"C Yu","year":"2019","unstructured":"Yu C, Li X, Hou Y, Meng X, Wang D, Liu J, et al. Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats. Molecules. 2019;24:146.","journal-title":"Molecules"},{"key":"1581_CR50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/art.38871","volume":"67","author":"C Sohc","year":"2015","unstructured":"Sohc C, Lee A, Qiao Y. Prolonged TNF primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheum. 2015;67:86\u201395.","journal-title":"Arthritis Rheum"},{"key":"1581_CR51","doi-asserted-by":"crossref","unstructured":"Kumar J, Venkateshwaran K, Vaidevi S, Vijaya R, Ruckmani K. Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis. Appl Nanosci 2019;1\u20139.","DOI":"10.1007\/s13204-019-00976-9"},{"issue":"3","key":"1581_CR52","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s11095-016-2094-y","volume":"34","author":"V Kumar","year":"2017","unstructured":"Kumar V, Leekha A, Tyagi A, Kaul A, Mishra AK, Verma AK. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis. Pharm Res. 2017;34(3):654\u201367.","journal-title":"Pharm Res"}],"updated-by":[{"DOI":"10.1208\/s12249-020-1634-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000}}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1581-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T14:03:43Z","timestamp":1616594623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1581-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1581-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1208\/s12249-020-1634-2","URL":"https:\/\/doi.org\/10.1208\/s12249-020-1634-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"34"}}